Valuation: Light AI Inc.

Market Cap 1.84Cr 1.3Cr 1.14Cr 1.08Cr 98.21L 124.63Cr 1.85Cr 13Cr 4.99Cr 64Cr 4.88Cr 4.78Cr 204.63Cr P/E 2024
-0.75x
P/E 2025 -0.89x
Enterprise Value 1.19Cr 84.37L 74.03L 69.92L 63.72L 81Cr 1.2Cr 8.37Cr 3.24Cr 41Cr 3.17Cr 3.1Cr 132.77Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
93.33%
Yield 2024 *
-
Yield 2025 -
1 day-4.43%
1 week+3.66%
Current month-23.38%
1 month-30.91%
3 months-38.16%
6 months+39.95%
Current year+23.93%
1 week 0.09
Extreme 0.09005
0.12
1 month 0.09
Extreme 0.09005
0.14
Current year 0.04
Extreme 0.0375
0.29
1 year 0.04
Extreme 0.0375
0.29
3 years 0.04
Extreme 0.0375
0.55
5 years 0.04
Extreme 0.0375
0.55
10 years 0.04
Extreme 0.0375
0.55
Change 5-day change 1-year change 3-year change Capi.($)
-4.43%+3.66% - - 1.3Cr
+2.12%+7.87%-3.30%+40.77% 4.54TCr
-1.63%-5.05%-46.65%+101.22% 1.18TCr
+2.59%-1.45%-7.46%+118.04% 554.06Cr
+1.05%-3.11%+48.73% - 427.55Cr
-5.25%-11.61% - - 194.45Cr
+1.91%+4.44%+9.57%-26.15% 153.54Cr
+0.08%-1.95%-35.57% - 100.78Cr
-0.61%-3.19%+9.98%+150.00% 96Cr
-1.14%-5.77%+30.96%+41.32% 86Cr
Average -0.53%-2.20%+0.78%+70.87% 815.33Cr
Weighted average by Cap. +1.19%+3.42%-7.27%+58.08%

Financials

2024 2025
Net sales - -
Net income -1.31Cr -92.66L -81.31L -76.8L -69.99L -89Cr -1.32Cr -9.19Cr -3.56Cr -45Cr -3.48Cr -3.4Cr -145.82Cr -1.61Cr -1.14Cr -1Cr -94.53L -86.14L -109.32Cr -1.62Cr -11Cr -4.38Cr -56Cr -4.28Cr -4.19Cr -179.49Cr
Net Debt -1.52Cr -1.07Cr -94.11L -88.88L -81L -102.79Cr -1.53Cr -11Cr -4.12Cr -53Cr -4.03Cr -3.94Cr -168.77Cr -64.56L -45.66L -40.07L -37.84L -34.49L -44Cr -65.02L -4.53Cr -1.75Cr -22Cr -1.71Cr -1.68Cr -72Cr
Logo Light AI Inc.
Light AI Inc. is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. It is engaged in developing screening and diagnostic solutions aimed at improving healthcare delivery worldwide. The Company is developing a technology platform which represents the next generation of patient management that it applies AI algorithms to smartphone images, starting with images of Strep A and anticipated expansion with COVID19 along with other medical conditions, to identify the disease in seconds. Its app-based solution requires no swabs, lab tests or proprietary hardware of any kind. Its AI powered technology offers screening and diagnostic tools designed to address critical healthcare challenges. Its technology offers a significant advancement in the identification of GAS pharyngitis. Its approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin.
Employees
6
Date Price Change Volume
25/26/25 $0.1046 -4.43% 1,235
24/26/24 $0.1094 +2.82% 7,829
23/26/23 $0.1064 +3.15% 4,000
22/26/22 $0.1032 -10.78% 21,000
21/26/21 $0.1156 +14.57% 1,219